Detalhe da pesquisa
1.
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
J Med Virol
; 96(2): e29456, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38329187
2.
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations.
medRxiv
; 2024 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38699322
3.
Plasma CXCL8 and MCP-1 as biomarkers of latent tuberculosis infection.
medRxiv
; 2023 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37609153
4.
Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India - a cohort study.
Lancet Reg Health Southeast Asia
; 19: 100272, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38076717
5.
Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study.
PLOS Glob Public Health
; 3(11): e0002327, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37992019
6.
Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine.
Front Med (Lausanne)
; 9: 887974, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35770011
7.
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
Front Public Health
; 10: 1018399, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36211690